Panacea Biotec Archives

This landmark trial aims to evaluate the efficacy of DengiAll, India’s indigenous tetravalent dengue vaccine developed by Panacea Biotec

Breakthrough: India starts Phase 3 trial for tetravalent dengue vaccine

PGurus Newsdesk - August 14, 2024 0

India’s DengiAll vaccine enters crucial Phase 3 testing In a groundbreaking development, the Indian Council of Medical Research (ICMR) and Panacea Biotec announced on Wednesday...

Tag: Panacea Biotec

Breakthrough: India starts Phase 3 trial for tetravalent dengue vaccine

BOOKS

M.V.R. Sastry’s Devudunnadu Jagratha – A detailed examination – Part 1

Prof Hari Om’s new book “Buddhists Playing With Fire” hits the...

Review of “The Manthan Code” (author Shambhu Sundriyal)

‘I Have the Streets’ – R Ashwin & Sidharth Monga

K Parasaran Miscellany: A book that needs to be read by...